EcoDrugPlus

Glutamate Metabotropic Receptor 4

Ensembl ID : ENSCPOG00000000288
Gene Symbol: GRM4
2 Cross references
266 Possible Orthologues:

Glutamate Metabotropic Receptor 5

Ensembl ID : ENSCPOG00000009056
Gene Symbol: GRM5
2 Cross references
278 Possible Orthologues:

Glutaminase

Ensembl ID : ENSCPOG00000012668
Gene Symbol: GLS
2 Cross references
305 Possible Orthologues:

Glutathione S-Transferase Pi 1

Ensembl ID : ENSCPOG00000020253
Gene Symbol: GSTP1
2 Cross references
172 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha

Ensembl ID : ENSCPOG00000026896
Gene Symbol: GSK3A
2 Cross references
259 Possible Orthologues:

Glycogen Synthase Kinase 3 Beta

Ensembl ID : ENSCPOG00000014311
Gene Symbol: GSK3B
2 Cross references
244 Possible Orthologues:

Gonadotropin Releasing Hormone Receptor

Ensembl ID : ENSCPOG00000014609
Gene Symbol: GNRHR
2 Cross references
242 Possible Orthologues:

Growth Hormone Releasing Hormone Receptor

Ensembl ID : ENSCPOG00000011400
Gene Symbol: GHRHR
2 Cross references
193 Possible Orthologues:

Growth Hormone Secretagogue Receptor

Ensembl ID : ENSCPOG00000014041
Gene Symbol: GHSR
2 Cross references
211 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 1

Ensembl ID : ENSCPOG00000011041
Gene Symbol: GUCY1A1
4 Cross references
203 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 2

Ensembl ID : ENSCPOG00000000335
Gene Symbol: GUCY1A2
2 Cross references
203 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Beta 1

Ensembl ID : ENSCPOG00000014932
Gene Symbol: GUCY1B1
4 Cross references
211 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).